Bone marrow‐derived extracellular vesicles modulate the abundance of infiltrating immune cells in the brain and exert an antiviral effect against the Japanese encephalitis virus
Abstract Mesenchymal stem cells (MSCs) have regenerative capacity and have reported a beneficial effect on the Japanese encephalitis virus (JEV) in an encephalitis model. However, the MSCs do not cross the blood–brain barrier and have other disadvantages limiting their therapeutic utility scope. Rec...
Main Authors: | Naina Soni, Aarti Tripathi, Sriparna Mukherjee, Suchi Gupta, Sujata Mohanty, Anirban Basu, Arup Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | FASEB BioAdvances |
Subjects: | |
Online Access: | https://doi.org/10.1096/fba.2022-00071 |
Similar Items
-
Regulation of Onecut2 by miR-9-5p in Japanese encephalitis virus infected neural stem/progenitor cells
by: Shivangi Sharma, et al.
Published: (2024-03-01) -
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
by: Kumar Saurabh Srivastava, et al.
Published: (2023-03-01) -
Current Advances in Japanese Encephalitis Virus Drug Development
by: Jiao Guo, et al.
Published: (2024-01-01) -
Potential Role of Birds in Japanese Encephalitis Virus Zoonotic Transmission and Genotype Shift
by: Muddassar Hameed, et al.
Published: (2021-02-01) -
A highly pathogenic porcine reproductive and respiratory syndrome virus candidate vaccine based on Japanese encephalitis virus replicon system
by: Pingsheng Hu, et al.
Published: (2017-07-01)